Non-Hodgkin's Lymphoma

European Journal of Cancer

Volumn 34, Issue 3, 1998, Pages 359-362

  Patte, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MEGADOSE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0032005570     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10142-3     Document Type: Article

References (23)

1. 1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood 1994, 84, 1361-1392.
2. 2. Patte C, Philip T, Rodary C, et al. High survival rate in advanced stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy. Results of a randomized trial from the French Pediatric Oncology Society (SFOP) on 216 children. J Clin Oncol 1991, 9, 123-132.
3. 3. Patte C, Michon J, Berendt H, et al. Results of the LMB 89 protocol for childhood B-cell lymphoma and leukemia. Study of the SFOP. Med Ped Oncol 1997, 29, 358 (abstract SIOP).
4. 4. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage. A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995, 13, 359-372.
5. 5. Reiter A, Schrappe M, Tiemann M, et al. Treatment results for B-cell lymphomas and acute B-cell leukemia in the German-Austrian-Swiss study NHL-BFM90. A report of the BFM group. Risk group definition, treatment strategy and preliminary results for B-cell neoplasias in trial NHL-BFM 90. Med Ped Oncol 1997, 29, 358 (abstract SIOP).
6. 6. Magrath IT, Adde M, Shad A, et al. Adults and children with small non cleaved cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996, 14, 925-934.
7. 7. Brecher M, Murphy SB, Bowman P, et al. Fractionated cyclophosphamide and back to high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas: a randomised trial of the Pediatric Oncology Group. Med Ped Oncol 1997, 29, 526-533.
8. 8. Bowman WP, Shuster J, Cook B, et al. Improved survival for children with B cell (slg+) acute lymphoblastic leukemia and stage IV small non-cleaved cell lymphoma. J Clin Oncol 1997, 14, 1252-1261.
9. 9. Pinkerton CR, Hann I, Eden OB, Gerrard M, Berry J, Mott MG. Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86). How much treatment is needed? Br J Cancer 1991, 64, 583-587.
10. 10. Gentet JC, Patte C, Quintana E, et al. Phase II study of cytarabine and Etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology. J Clin Oncol 1990, 8, 661-665.
11. 11. Jansen P, Shrappe M, Zimmerman M, et al. Intraventricularly applied chemotherapy and intensive systemic therapy is effective for CNS positive patients with Burkitt-type lymphomas or acute B-cell leukemia (B-ALL). Med Ped Oncol 1997, 29, 359 (abstract SIOP).
12. 12. Magrath IT, Haddy TB, Adde MA. Treatment of patients with high grade Non-Hodgkin's Lymphomas and central nervous system involvement: is radiation an essential component of therapy? Leukemia and Lymphoma 1996, 21, 99-105.
13. 13. Sakiroglu O, Patte C, Michon J, et al. Use of Uricozyme and occurrence of metabolic problems during initial phase of the LMB89 protocol. Med Ped Oncol 1997, 29, 331 (abstract SIOP).
14. 14. Patte C, Michon J, Laplanche A, et al. Results of a randomised trial on prophylactic G-CSF during induction treatment of Non-Hodgkin's Lymphoma. Med Ped Oncol 1997, 29, 360 (abstract SIOP).
15. 15. Furman W, Baker S, Pratt C, et al. Escalating systemic exposure of continuous infusion Topotecan in children with recurrent acute leukemia. J Clin Oncol 1996, 14, 1504-1511.
16. 16. Patte C, Kalifa C, Flamant F, et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non B-cell lymphoma. Med Ped Oncol 1992, 20, 105-113.
17. 17. Schrappe M, Tiemann M, Ludwig WD, et al. Risk adaptated therapy for lymphoblastic T-cell lymphoma: results from trials NHL-BFM 86 and 90. Med Ped Oncol 1997, 29, 356 (abstract SIOP).
18. 18. Desai S, Amylon M, Schween MR, Laver J, Shuster J, Murphy S. Outcome of advanced stage (III-IV) lymphoblastic non-Hodgkin lymphoma. A Pediatric Oncology Group study. Med Ped Oncol 1997, 29, 356.
19. 19. Reiter A, Schrappe M, Tiemann M, et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 1994, 12, 899-908.
20. 20. Brugières L, Le Deley MC, Pacquement H, et al. Anaplastic large cell lymphoma in children: analysis of 63 patients enrolled in two consecutive studies of the SFOP. Med Ped Oncol 1997, 29, 357.
21. 21. Hutchinson RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB. B-cell lineage confers a favorable outcome among children and adolescents with large cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol 1995, 13, 2023-2032.
22. 22. Katz JA, Shuster JJ, Ravindnanath Y, et al. Secondary acute myelogenous leukemia following intensive treatment for childhood T-cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma treated with teniposide. Proc Am Soc Clin Oncol 1995, abstract no. 1040.
23. 23. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early stage non Hodgkin's lymphoma. N Engl J Med 1997, 337, 1259-1266.